SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001082554-08-000041
Filing Date
2008-05-01
Accepted
2008-05-01 17:35:54
Documents
1
Period of Report
2008-04-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3973
  Complete submission text file 0001082554-08-000041.txt   5773
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address C/O UNITED THERAPEUTICS CORP 1110 SPRING STREET SILVER SPRING MD 20910 3016089292
CAUSEY CHRISTOPHER (Reporting) CIK: 0001237334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 08795873